(S (NP (NP (NP (JJ Malignant) (NNP Pleural) (NNP Mesothelioma)) (PRN (-LRB- -LRB-) (NP (NNP MPM)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ malignant) (NN mesothelioma)) (PRN (-LRB- -LRB-) (NP (NNP MM)) (-RRB- -RRB-)))) (VP (VBZ is) (NP (NP (DT an) (JJ atypical) (, ,) (JJ aggressive) (NN tumor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ matures) (PP (IN into) (NP (NP (NN cancer)) (PP (IN in) (NP (NP (DT the) (NN pleura)) (, ,) (NP (NP (DT a) (NN stratum)) (PP (IN of) (NP (NN tissue))) (VP (VBG bordering) (NP (DT the) (NNS lungs))))))))))))) (. .))
(S (S (NP (NP (NN Diagnosis)) (PP (IN of) (NP (NNP MPM)))) (VP (VBZ is) (ADJP (JJ difficult)))) (CC and) (S (NP (PRP it)) (VP (VBZ accounts) (PP (IN for) (NP (NP (QP (IN about) (JJ seventy-five)) (NN percent)) (PP (IN of) (NP (NP (DT all) (NNS mesothelioma)) (VP (VBD diagnosed) (ADVP (RB yearly)) (PP (IN in) (NP (NP (DT the) (NNP United) (NNPS States)) (PP (IN of) (NP (NNP America)))))))))))) (. .))
(S (S (VP (VBG Being) (NP (DT a) (JJ fatal) (NN disease)))) (, ,) (NP (NP (JJ early) (NN identification)) (PP (IN of) (NP (NNP MPM)))) (VP (VBZ is) (ADJP (JJ crucial) (PP (IN for) (NP (JJ patient) (NN survival))))) (. .))
(S (NP (PRP$ Our) (NN study)) (VP (VP (NNS implements) (NP (JJ logistic) (NN regression))) (CC and) (VP (VBZ develops) (NP (NN association) (NNS rules))) (SBAR (S (VP (TO to) (VP (VB identify) (NP (NP (JJ early) (NN stage) (NNS symptoms)) (PP (IN of) (NP (NNP MM))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD retrieved) (NP (NP (JJ medical) (NNS reports)) (VP (VBN generated) (PP (IN by) (NP (NNP Dicle) (NNP University)))))) (CC and) (VP (VBN implemented) (NP (JJ logistic) (NN regression)) (S (VP (TO to) (VP (VB measure) (NP (DT the) (NN model) (NN accuracy))))))) (. .))
(S (NP (PRP We)) (VP (VBD conducted) (NP (NP (PRN (-LRB- -LRB-) (DT a) (-RRB- -RRB-)) (JJ logistic) (NN correlation)) (, ,) (NP (PRN (-LRB- -LRB-) (NN b) (-RRB- -RRB-)) (NNP Omnibus) (NN test)) (CC and) (NP (PRN (-LRB- -LRB-) (NN c) (-RRB- -RRB-)) (NNP Hosmer) (CC and) (NNP Lemeshow) (NN test))) (PP (IN for) (NP (NN model) (NN evaluation)))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD developed) (NP (NP (NN association) (NNS rules)) (PP (IN by) (NP (NP (NN confidence)) (, ,) (NP (NN rule) (NN support)) (, ,) (NP (NN lift)) (, ,) (NP (NN condition) (NN support)) (CC and) (NP (NN deployability)))))) (. .))
(S (NP (NNP Categorical) (JJ logistic) (NN regression)) (VP (VBZ increases) (NP (DT the) (NN training) (NN accuracy)) (PP (IN from) (NP (CD 72.30) (NN %))) (PP (TO to) (NP (CD 81.40) (NN %))) (PP (IN with) (NP (NP (DT a) (VBG testing) (NN accuracy)) (PP (IN of) (NP (CD 63.46) (NN %)))))) (. .))
(S (NP (DT The) (NN study)) (ADVP (RB also)) (VP (VBZ shows) (NP (NP (DT the) (JJ top) (CD 5) (NNS symptoms)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (RB mostly) (JJ likely) (S (VP (VBZ indicates) (NP (NP (DT the) (NN presence)) (PP (IN in) (NP (NNP MM)))))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ concludes) (SBAR (IN that) (S (S (VP (VBG using) (NP (JJ predictive) (NN modeling)))) (VP (MD can) (VP (VB enhance) (NP (NP (JJ primary) (NN presentation) (CC and) (NN diagnosis)) (PP (IN of) (NP (NNP MM))))))))) (. .))
